Markets
Sai Life Sciences Q1 FY27: Double-Digit Growth Fails to Impress — Shares Tumble 4%
Sai Life Sciences delivered double-digit revenue growth in Q1 FY27, yet the stock dropped sharply on results day — a classic 'sell the news' reaction that reveals deeper market concerns about margins and valuation. Here is the full breakdown of what drove the move and what comes next.